(Dec. 6, 2012) -- To support an increase in research productivity at UTSA, the Office of the Vice President for Research announced that Bernard Arulanandam, Ph.D., M.B.A., will serve as assistant vice president for research support. Arulanandam's position, effective Dec. 1, was created as part of UTSA's research administration restructuring and reports directly to the vice president for research.
In his new role, Arulanandam will coordinate a series of programs and services to promote research productivity in all UTSA colleges. His responsibilities will include:
Since 2009, Arulanandam has served as associate dean of research for scientific innovation in the UTSA College of Sciences. He also is the Jane and Roland Blumberg Professor in Biology and director of the South Texas Center for Emerging Infectious Diseases. His research in the Department of Biology focuses on bacterial infections and the body's immune response to bacterial diseases with the goal of developing vaccines and therapies for prevention and treatment. Much of his work centers on studying mucosal surfaces, which are significant entry points for pathogens and often serve as the body's first line of defense.
Arulanandam joined the UTSA faculty in 2001. Since that time, he has focused most of his research on two bacteria. The first, Franciscella tularensis, causes the respiratory infection tularemia, or rabbit fever. Tularemia is particularly dangerous because it can be used easily as a bioweapon. He also is working to develop a vaccine against Chlamydia trachomatis, the bacterium that causes the sexually transmitted disease chlamydia.
Throughout his career, Arulanandam has published more than 75 research papers. He receives funding from many agencies including the National Institutes of Health and the Department of Defense. Additionally, he is one of the scientific directors of the San Antonio Vaccine Development Center (a partnership between UTSA, the UT Health Science Center, Southwest Research Institute and Texas Biomed), and he directs the Center of Excellence in Infection Genomics funded by the Department of Defense. The DoD center supports microbiology research, teaching and outreach activities aligned with Army priorities.
In 2009, Arulanandam and his UT Health Science Center colleague Guangming Zhong established an exclusive license and sponsored research agreement with Merck and Co. Inc. to develop a vaccine for chlamydia, which causes an estimated 2.3 million cases of infection in the United States. The Merck license was the first revenue-producing license for any technology developed at UTSA.
"Dr. Arulanandam is an accomplished researcher and educator who has a thorough understanding of what it takes to develop and sustain productive research programs," said John Frederick, UTSA provost and interim vice president for research. "He is respected by both his peers at the university and his scientific colleagues around the world. At UTSA, he has made great strides to commercialize the discoveries made in his laboratories, and he has worked steadily and successfully to help shape the way we support researchers."
The Office of the Vice President for Research is restructuring to become more productive and efficient with its resources. In addition to new staff positions such as the research ombudsman, the restructuring calls for the creation of six new Research Service Centers. The centers will provide scholars with seamless sponsored-project administration including grant opportunity identification, proposal preparation and submission, grant award processing and management, and grant closeout procedures.
UTSA prides itself on giving students a well-rounded education. Combining a top-tier academic program with opportunities for personal growth prepares students to compete in a global economy. And that's not all. They learn to be informed and engaged citizens as well. At the heart of that academic program is an award-winning core curriculum.
For four consecutive years, UTSA has received an A-rating from the American Council of Trustees and Alumni for the caliber of its core curriculum. According to ACTA, UTSA requires its students to take six of the seven courses deemed "crucial" to a well-rounded education: composition, literature, U.S. government or history, economics, mathematics and science. Only a handful of other institutions in the U.S. are giving students these tools, which are needed to succeed in careers and the community.
Did you know? UTSA is one of only three Texas institutions and 23 in the United States to receive the highest rating for its core curriculum in the 2014-2015 edition of the ACTA's "What Will They Learn?" report.
Cheer on the UTSA Roadrunners at their home-opener against the Kansas State Wildcats.
Alamodome, 100 Montana St.
As part of National Recovery Month, a panel of substance abuse practitioners and members of the recovery community will discuss issues related to substance abuse treatment and recovery.
Durango Building 1.124 (DB 1.124), Downtown Campus
Love of theater, history leads Lee grad to pursue anthropology degree
The University of Texas at San Antonio is dedicated to the advancement of knowledge through research and discovery, teaching and learning, community engagement and public service. As an institution of access and excellence, UTSA embraces multicultural traditions and serves as a center for intellectual and creative resources as well as a catalyst for socioeconomic development and the commercialization of intellectual property - for Texas, the nation and the world.
To be a premier public research university, providing access to educational excellence and preparing citizen leaders for the global environment.
We encourage an environment of dialogue and discovery, where integrity, excellence, inclusiveness, respect, collaboration and innovation are fostered.